Advancements in The Ongoing Puzzle to Understand c-SRC
Tuesday, 21 February 2023
Nearly a half-century ago, sequences from the Rous Sarcoma Virus were used to identify the first proto-oncogene and the first of a family of non-receptor tyrosine kinases: c-SRC. Unlike its viral counterpart (v-SRC), c-SRC exists in both an active and inactive state. It is produced in almost every cell type, but expressed highest in the
- Published in Emerging Targets, Innate Immunity
No Comments
How a Tyrosine Kinase Inhibitor Is Giving Hope to Lung Cancer Patients
Tuesday, 20 August 2019
According to the American Cancer Society, lung cancer is the leading cause of cancer death each year and accounts for approximately 13% of all new cases. The most common type being non-small cell lung cancer (NSCLC). Although smoking is the biggest contributor, other factors such as genetics and environmental pollutants contribute to lung cancer of
- Published in Emerging Targets